Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Change in Account Payables (2023 - 2026)

Contineum Therapeutics' Change in Account Payables history spans 4 years, with the latest figure at $490000.0 for Q1 2026.

  • Quarterly Change in Account Payables fell 73.28% to $490000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.2 million through Mar 2026, down 172.68% year-over-year, with the annual reading at -$869000.0 for FY2025, 176.16% down from the prior year.
  • Change in Account Payables came in at $490000.0 for Q1 2026, up from $162000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.8 million in Q1 2025 to a low of -$1.6 million in Q2 2025.
  • The 4-year median for Change in Account Payables is $170000.0 (2024), against an average of $58615.4.
  • The largest YoY upside for Change in Account Payables was 2720.0% in 2025 against a maximum downside of 1067.06% in 2025.
  • Contineum Therapeutics' Change in Account Payables stood at -$625000.0 in 2023, then soared by 160.48% to $378000.0 in 2024, then tumbled by 57.14% to $162000.0 in 2025, then soared by 202.47% to $490000.0 in 2026.
  • Per Business Quant, the three most recent readings for CTNM's Change in Account Payables are $490000.0 (Q1 2026), $162000.0 (Q4 2025), and -$1.2 million (Q3 2025).